v3.25.2
Discontinued Operations - Sale of VitaMedica (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Jun. 30, 2024
Jun. 30, 2023
Accounts receivable net of allowance for doubtful accounts   $ 219,600      
Fixed assets, net of accumulated depreciation       $ 1,268,355 $ 913,246
Discontinued Operations - Sale of VitaMedica [Member]          
Revenues $ 2,673,744   $ 6,708,021 8,707,268 7,610,949
Cost of sales 587,142   1,480,486 2,051,854 1,362,036
Sales general and administrative expenses 1,888,490   4,694,350 6,076,257 5,891,301
Deprecation and amortization 115,896   353,646 425,263 527,634
Other expenses       (59,742) (212,427)
Income (loss) from discontinued operations       213,636 (382,449)
Accounts receivable net of allowance for doubtful accounts 444,730   444,730 0 289,416
Fixed assets, net of accumulated depreciation $ 54,791   $ 54,791 0 83,840
Total assets       0 $ 4,875,757
Total liabilities       $ 0